Evidence map›Paper›PMID 27063012›Full record

ArticleApplied microbiology and biotechnology2016

Reverse transcription strand invasion based amplification (RT-SIBA): a method for rapid detection of influenza A and B.

Kevin Eboigbodin, Sanna Filén, Tuomas Ojalehto, Mirko Brummer, Sonja Elf, Kirsi Pousi, Mark Hoser

Open access · hybridAbstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kevin EboigbodinResearch and Development, Orion Diagnostica Oy, P. O. BOX 83, FI-02101, Espoo, Finland. kevin.eboigbodin@oriondiagnostica.fi.
Sanna FilénResearch and Development, Orion Diagnostica Oy, P. O. BOX 83, FI-02101, Espoo, Finland.
Tuomas OjalehtoResearch and Development, Orion Diagnostica Oy, P. O. BOX 83, FI-02101, Espoo, Finland.
Mirko BrummerResearch and Development, Orion Diagnostica Oy, P. O. BOX 83, FI-02101, Espoo, Finland.
Sonja ElfResearch and Development, Orion Diagnostica Oy, P. O. BOX 83, FI-02101, Espoo, Finland.
Kirsi PousiResearch and Development, Orion Diagnostica Oy, P. O. BOX 83, FI-02101, Espoo, Finland.
Mark HoserMolecular Biology, GeneForm Technologies, Broadstairs, UK.
Orion Corporation (Finland) · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid and accurate diagnosis of influenza viruses plays an important role in infection control, as well as in preventing the misuse of antibiotics. Isothermal nucleic acid amplification methods offer significant advantages over the polymerase chain reaction (PCR), since they are more rapid and do not require the sophisticated instruments needed for thermal cycling. We previously described a novel isothermal nucleic acid amplification method, 'Strand Invasion Based Amplification' (SIBA®), with high analytical sensitivity and specificity, for the detection of DNA. In this study, we describe the development of a variant of the SIBA method, namely, reverse transcription SIBA (RT-SIBA), for the rapid detection of viral RNA targets. The RT-SIBA method includes a reverse transcriptase enzyme that allows one-step reverse transcription of RNA to complementary DNA (cDNA) and simultaneous amplification and detection of the cDNA by SIBA under isothermal reaction conditions. The RT-SIBA method was found to be more sensitive than PCR for the detection of influenza A and B and could detect 100 copies of influenza RNA within 15 min. The development of RT-SIBA will enable rapid and accurate diagnosis of viral RNA targets within point-of-care or central laboratory settings.

Indexed as

Molecular Diagnostic TechniquesNucleic Acid Amplification TechniquesReverse TranscriptionDNA PrimersHumansInfluenza A virusInfluenza B virusInfluenza, HumanPoint-of-Care SystemsRNA, ViralSensitivity and SpecificityDNA PrimersRNA, ViralAmplificationDiagnosticsInfluenzaIsothermalRNAVirus

Identifiers

PMID27063012
PMCPMC4875950
OpenAlexW2317402451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.